SensiGene Cystic Fibrosis (CF) Carrier Screening Test

Friday, 20 November, 2009 | Supplied by: Agena Bioscience Inc


The SensiGene Cystic Fibrosis (CF) Carrier Screening Test screens for 103 mutations and five variants, including the 23 mutations recommended by the American College of Medical Genetics (ACMG).

The test has been shown to identify each of the 103 mutations and five variants through genomic DNA and DNA control testing and offers good detection rates and broader ethnic coverage when compared to the standard ACMG 23 recommended mutations panel.

Because of the increased difficulty in assigning a single ethnicity to an individual, expanded CF panels can provide increased sensitivity for CF carrier screening for many individuals. Having a more comprehensive mutation panel is important as one in 17 CF carriers may be missed using a standard ACMG 23 CF carrier screening panel.

The test employs the MassArray system, which allows direct and label-free analysis of nucleic acids.

Online: agenabio.com
Phone: 07 3088 1600
Related Products

Maxwell Biosystems MaxTwo high-density microelectrode array (HD-MEA) system

The next-generation multiwell HD-MEA captures high-quality signals at subcellular resolution from...

Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit

The kit includes a comprehensive set of optimised screening reagents and conditions that...

Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit

The kit enables simultaneous detection, discrimination and absolute quantification of seven known...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd